Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Bristol-Myers Squibb Co shares valued at $3,702 were sold by Hickey Benjamin on May 09 ’25. At $38.01 per share, Hickey Benjamin sold 97 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Hirawat Samit purchased 4,250 shares, netting a total of over 202,215 in proceeds. Following the buying of shares at $47.58 each, the insider now holds 83,513 shares.
Before that, BOERNER CHRISTOPHER S. had added 2,000 shares to its account. In a trade valued at $110,096, the Chief Executive Officer bought Bristol-Myers Squibb Co shares for $55.05 each. Upon closing the transaction, the insider’s holdings increased to 2,000 shares, worth approximately $4.81 million.
As published in their initiating research note from Piper Sandler on April 22, 2025, Bristol-Myers Squibb Co [BMY] has been an Overweight. Analysts at Cantor Fitzgerald started covering the stock with ‘”a Neutral”‘ outlook in a report released in late April. As of December 16, 2024, Jefferies has increased its “Hold” rating to a “Buy” for BMY.
Analyzing BMY Stock Performance
On last trading session,, Bristol-Myers Squibb Co [NYSE: BMY] plunged -1.88% to $45.98. The stock’s lowest price that day was $45.81, but it reached a high of $47.26 in the same session. During the last five days, there has been a drop of approximately -6.12%. Over the course of the year, Bristol-Myers Squibb Co shares have dropped approximately -8.86%.
Support And Resistance Levels for Bristol-Myers Squibb Co (BMY)
RSI (Relative Strength Index) is 41.38 on the 14-day chart, showing neutral technical sentiment.
Is Bristol-Myers Squibb Co subject to short interest?
Stocks of Bristol-Myers Squibb Co saw a sharp rise in short interest on 2025-07-15 jumping by 4.77 million shares to 38.38 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 33.61 million shares. A jump of 12.43% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.58 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.58.
Which companies own the most shares of Bristol-Myers Squibb Co (BMY)?
In terms of Bristol-Myers Squibb Co share price expectations, FactSet research, analysts set an average price target of 68 in the next 12 months, up nearly 45.11% from the previous closing price of $46.86. Analysts anticipate Bristol-Myers Squibb Co stock to reach 84 by 2025, with the lowest price target being 65. In spite of this, 14 analysts ranked Bristol-Myers Squibb Co stock as Hold at the end of 2025.
